Parnax Lab Intrinsic Value
PARNAXLAB Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹277.20 | ₹221.76 - ₹332.64 | +129.5% | EPS: ₹12.60, Sector P/E: 22x |
| Book Value Method | asset | ₹138.33 | ₹124.50 - ₹152.16 | +14.5% | Book Value/Share: ₹69.17, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹241.60 | ₹217.44 - ₹265.76 | +100.0% | Revenue/Share: ₹210.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹241.60 | ₹217.44 - ₹265.76 | +100.0% | EBITDA: ₹36.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹302.00 | ₹241.60 - ₹362.40 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹80.64 | ₹72.58 - ₹88.70 | -33.2% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹194.67 | ₹175.20 - ₹214.14 | +61.2% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹186.67 | ₹168.00 - ₹205.34 | +54.5% | ROE: 19.3%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹138.33 | ₹124.50 - ₹152.16 | +14.5% | EPS: ₹12.60, BVPS: ₹69.17 |
Want to compare with current market value? Check PARNAXLAB share price latest .
Valuation Comparison Chart
PARNAXLAB Intrinsic Value Analysis
What is the intrinsic value of PARNAXLAB?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Parnax Lab (PARNAXLAB) is ₹194.67 (median value). With the current market price of ₹120.80, this represents a +61.2% variance from our estimated fair value.
The valuation range spans from ₹80.64 to ₹302.00, indicating ₹80.64 - ₹302.00.
Is PARNAXLAB undervalued or overvalued?
Based on our multi-method analysis, Parnax Lab (PARNAXLAB) appears to be trading below calculated value by approximately 61.2%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.03 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 2.29 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 19.3% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 13.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.33x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Parnax Lab
Additional stock information and data for PARNAXLAB
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹32 Cr | ₹24 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹16 Cr | ₹0 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹21 Cr | ₹16 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹9 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹6 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |